March 1, 2017. By Gordon Gibb.
New Orleans, LA: It could be mere co-incidence, but on the eve of the National Basketball Association (NBA) All Star Game that served to delay Xarelto bellwether trials by a month, the manufacturers of Xarelto chose to highlight an aging NBA all-star player who expounds upon the virtues of rivaroxaban (Xarelto) and professes to use it himself. As such, a visit to the official Xarelto website showcases the former All-American player, rather than the potential for a Xarelto bleeding issue.Read [ Plaintiffs Looking for a Slam Dunk in First Xarelto Bellwether Trial This Month ]
February 3, 2017. By Gordon Gibb.
New Orleans, LA: The maiden bellwether Xarelto lawsuit was originally scheduled to commence this month, an important event given that the number of Xarelto Bleeding Issue cases now exceeds 10,000.Read [ Xarelto Bellwether Pushed Back by NBA All-Star Game ]
January 6, 2017. By Gordon Gibb.
Orleans, LA: The massive Xarelto lawsuit portfolio, currently with almost 14,000 cases pending in multidistrict litigation, will see its first bellwether trial roll out in March with additional bellwethers slated for April and May. Plaintiffs allege that Xarelto, a blood thinner, triggered Xarelto bleeding complications without benefit of an available antidote to reverse the blood thinning properties of the anticoagulant.Read [ First Xarelto Bellwether Trial Due in March, Others to Follow in 2017 ]
December 5, 2016. By Gordon Gibb.
Washington, DC: In spite of assurances by the US Food and Drug Administration (FDA) that a recall of a monitoring device used to help determine the safety and effectiveness of Xarelto did not adversely affect outcomes, some 7,200 Xarelto lawsuits have been filed and consolidated in multidistrict litigation. The first bellwether Xarelto lawsuit is now only months away, scheduled for February of next year.Read [ FDA Assurances Likely Not Enough to Satisfy Xarelto Litigants ]
November 2, 2016. By Jane Mundy.
Philadelphia, PA: To date, 950 Xarelto lawsuits that have been consolidated into a mass tort will be tried under the bellwether program slated for next summer at the earliest. Additionally, almost 3,000 cases make up the federal Xarelto multi-district litigation (MDL).Read [ Xarelto Mass Tort and MDL Grows ]
October 2, 2016. By Gordon Gibb.
New Orleans, LA: The expected wave of litigation stemming from Xarelto Bleeding complications has come to pass, with a parade of cases continuing to find harbor in Multi-District Litigation (In Re Xarelto MDL 2592, US District Court, Eastern District of Louisiana). More than 7,000 cases are pending, with the expectation of further cases given the deadline extension issued last month by US District Court Judge Eldon Fallon.Read [ Xarelto MDL Judge Orders Redacted Personnel Files of Two Bayer Doctors ]
September 22, 2016. By Jane Mundy.
Philadelphia, PA:Due to a flood of Xarelto complaints, Judge Eldon Fallon in the Multi-District Litigation is extending the filing deadline by another 90 days, adding to more than 7,000 cases pending in the Eastern District of Louisiana.Read [ Xarelto Lawsuits on the Rise ]
August 14, 2016. By Gordon Gibb.
Washington, DC: If anyone ever doubted the seriousness, and the compelling nature of Xarelto Bleeding complications and litigation stemming from Xarelto Side Effects, one need only look at the continuing rise in the number of Xarelto lawsuits.Read [ Xarelto Lawsuits Closing in on 7,000 ]
July 14, 2016. By Heidi Turner.
New Orleans, LA: With almost 6,000 Xarelto lawsuits consolidated for pretrial proceedings, and more being regularly filed, plaintiffs await the day that bellwether trials will be heard. Those bellwether cases will set the tone for future Xarelto litigation, and will show both sides what the experts have to say about Xarelto side effects.Read [ Almost 6,000 Lawsuits Consolidated in Xarelto Litigation ]
June 16, 2016. By Gordon Gibb.
New Orleans, LA: It was barely two months ago that consolidated lawsuits in the Xarelto Lawsuit multidistrict litigation numbered about 4,500. Today, there are in excess of 5,381 pending in US District Court for the Eastern District of Louisiana. Pundits from the outset held that Xarelto, akin to Pradaxa, would result in heavy litigation due to the way in which it was brought to market, the requirement for less monitoring, and the Achilles’ heel that is any lack of an antidote.Read [ Xarelto Lawsuits Continue Unabated, Now Over 5,000 and Growing in Number ]